## BACKGROUND. Because tumors require angiogenesis for growth, inhibiting angiogenesis is a promising strategy for treating cancer patients. Although numerous endogenous angiogenesis inhibitors have been discovered, the clinical evaluation of these agents has been hindered by high dose requirement
Experimental study of antiangiogenic gene therapy targeting VEGF in oral cancer
β Scribed by Yasuo Okada; Hikaru Ueno; Masataka Katagiri; Takahiro Oneyama; Kana Shimomura; Satoshi Sakurai; Izumi Mataga; Michiko Moride; Hitoshi Hasegawa
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 552 KB
- Volume
- 98
- Category
- Article
- ISSN
- 1618-1247
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We previously demonstrated that gene replacement of mouse macrophage metalloelastase (MME) into murine melanoma cells that grow rapidly and are MME deficient suppresses the primary tumor growth in vivo by halting angiogenesis. The aim of the present study was to evaluate the effectiveness of gene th
## Abstract Inhibition of tumor neovascularization has profound effects on the growth of solid tumors. Our previous studies have shown the effect of VEGF165βPE38 recombinant immunotoxin on proliferation and apoptosis in human umbilical vein endothelial cells __in vitro__. In this study, we explored
## Abstract We present a tumor gene therapy approach based on the use of regulatory sequences of the H19 gene that are differentially expressed between normal and cancer cells. We constructed expression vectors carrying the gene for the A fragment of diphtheria toxin (DTβA) or herpes simplex virus